BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8369083)

  • 1. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
    Holly A; Bujía J; Sanchez-Madrid F
    Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
    Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
    Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V; Holly A; Bujía J; Schulz P
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperproliferation-associated keratin 16 expression in cholesteatoma].
    Schilling V; Bujía J; Holly A; Schulz P
    Laryngorhinootologie; 1992 Nov; 71(11):584-7. PubMed ID: 1281411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
    Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteatoma or keratoma: A pathological approach.
    Marquet J
    Acta Otorhinolaryngol Belg; 1980; 34(1):5-11. PubMed ID: 7468193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factor in middle ear cholesteatoma.
    Huang T; Yan SD; Huang CC
    Am J Otolaryngol; 1989; 10(6):393-8. PubMed ID: 2688444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of calgranulin A and B in middle ear cholesteatoma].
    Holly A; Bujía J; Lempart K; Serge M
    Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
    Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
    HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin expression in middle ear cholesteatoma.
    Dallari S; Cavani A; Bergamini G; Girolomoni G
    Acta Otolaryngol; 1994 Mar; 114(2):188-92. PubMed ID: 7515549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteatoma of the middle ear in human patients. An ultrastructural study.
    Schaper J; van de Heyning J
    Arch Otolaryngol; 1976 Nov; 102(11):663-8. PubMed ID: 985197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent findings on the etiology and pathogenesis of cholesteatoma--an overview].
    Kastenbauer E; Schilling V; Bujía J
    Laryngorhinootologie; 1994 Jan; 73(1):2-6. PubMed ID: 8141949
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphotoxin in human middle ear cholesteatoma.
    Yan SD; Huang CC
    Laryngoscope; 1991 Apr; 101(4 Pt 1):411-5. PubMed ID: 1680210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why does middle ear cholesteatoma recur?
    Palva T; Mäkinen J
    Arch Otolaryngol; 1983 Aug; 109(8):513-8. PubMed ID: 6870643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
    Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
    Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.